terzepatide
ProductHeard on podcasts recently
Tirzepatide is an injectable medicine that activates GIP and GLP-1 receptors and is used to treat type 2 diabetes and chronic weight management.
Rank this week
—
Not in this week’s list
Share of the conversation
—
Reach this week
—
Tone this week
—
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of terzepatide per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 12 | 0.01‰ | 1 |
| Sep 26 | 0.01‰ | 1 |
| Sep 28 | 0.03‰ | 2 |
| Oct 16 | 0.01‰ | 1 |
| Oct 20 | 0.02‰ | 1 |
| Oct 28 | 0.02‰ | 2 |
| Oct 29 | 0.03‰ | 1 |
| Oct 31 | 0.03‰ | 1 |
| Nov 1 | 0.05‰ | 2 |
| Nov 2 | 0.09‰ | 5 |
Discussed alongside
Names that come up in the same conversations as terzepatide.
Embed this
Paste this on your site to show terzepatide's current trend:
<iframe src="https://podlume.ai/embed/e/terzepatide" width="360" height="220" style="border:0" loading="lazy" title="terzepatide on PodLume Trends"></iframe>